PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3442/12/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
GSK LinkedIn posts about Phase 3 RSV vaccine candidate and Covid-19 antibody trial
A concerned health professional complained about two GlaxoSmithKline UK Limited posts on the GSK corporate LinkedIn account (over 2.5m followers at the time; later over 2.8m, including 225,000+ fro…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3405/10/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
LEO
An anonymous complainant (described as a pharmaceutical physician) complained about 60 videos featuring UK health professionals and/or UK patients on the LEO Pharma Global YouTube channel. The Case…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3406/10/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi
A contactable complainant (anonymous; member of the public) complained about Chiesi’s respiratory website (www.chiesirespiratory.co.uk).Allegations included: advertising prescription-only medicin…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3424/11/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, non-contactable complainant (self-described health professional) complained about a GP Online article on switching asthma inhalers to help the NHS cut carbon emissions.The GP Online p…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3418/11/20
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo Pharma
A pharmaceutical physician complained about multiple aspects of Leo Pharma’s UK corporate website (www.leo-pharma.co.uk) and related transparency/disclosure practices.Clinical trials: The UK home…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3397/10/20
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Anonymous complainant v Leo (PharmaBoardroom executive interviews)
An anonymous, contactable complainant challenged a number of interviews with senior Leo Pharma executives published on pharmaboardroom.com over several years.The complainant said the site was UK-re…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3441/12/20
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Allergan social media tagging of HCP/clinic Instagram accounts mentioning Botox
A contactable ex-employee complained that Allergan product specialists were using Instagram to tag/link to customers (health professionals/clinics) whose accounts contained posts mentioning Botox (…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3411/10/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Daiichi Sankyo & AstraZeneca
A UK health professional complained about a Daiichi-Sankyo Inc LinkedIn post announcing initiation of the DESTINY-Breast05 Phase 3 trial for HER2+ early breast cancer, linking to a press release ab…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3430/11/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
AstraZeneca
A UK health professional complained about a named AstraZeneca employee’s LinkedIn post praising a Covid-19 vaccine programme and stating it “offers new hope to nations around the world”.The p…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3436/12/20
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag made a voluntary admission that it failed to maintain oversight and high standards for a nurse-led Stelara (ustekinumab) homecare service delivered by a third-party provider.The servi…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3428/11/20
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
LEO Pharma
An anonymous, contactable complainant challenged LEO Pharma’s use of LinkedIn, focusing on a global corporate page (“Leo Pharmaceuticals Ballerup DK”) that UK audiences were directed to from …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3343/5/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Shionogi Europe
A UK health professional complained about two Shionogi Europe posts on LinkedIn referring positively to Fetcroja (cefiderocol).Post 1 ("CHMP update") said: “Great news for patients…�…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3329/3/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim
A UK health professional complained about the pradaxa.co.uk landing page, which showed two routes: one for UK health professionals and one for “Patients Prescribed Pradaxa/Members of the Public�…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3315/3/20
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An individual complained about two LinkedIn posts about obesity made by Novo Nordisk employees around World Obesity Day 2020.The posts included pledges such as “Help stamp out weight stigma”, �…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3301/1/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Vifor
An anonymous, contactable complainant alleged the ivironheart.co.uk website (ref UK-NP-1900153, Sept 2019) was disguised promotion of Vifor’s Ferinject (ferric carboxymaltose) and that it was not…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3340/4/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
ViiV Healthcare breached Clause 4.1 and 9.1 after a promotional website PDF carried out-of-date pres
A UK health professional complained that a PDF downloaded from ViiV Exchange (a promotional website for health professionals) contained out-of-date prescribing information.The PDF covered four prod…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3331/4/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
A concerned UK health professional complained about a GlaxoSmithKline (GSK) advertisement for Relvar Ellipta in the December 2019 edition of Pulse magazine (viewed online).The complainant alleged t…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3341/5/20
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
During a separate complaint (Case AUTH/3328/4/20), GlaxoSmithKline UK Limited (GSK) reviewed 11 Avamys banner ads approved for UK use in 2019/20 and found two additional online banner advertisement…
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3321/3/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
A Menarini breached Clause 12.1 after PDF supplement lacked clear upfront company involvement (Ranex
A UK health professional complained that a supplement hosted on the Guidelines in Practice website and produced by A Menarini was disguised promotion for Ranexa (ranolazine).The item was titled: �…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3323/3/20
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva breached Clause 4.1 after DuoResp Spiromax prescribing information was hard to read in sponsore
A concerned UK health professional complained about the legibility of DuoResp Spiromax (budesonide/formoterol) prescribing information shown in a recorded webinar commissioned by Teva UK Limited (r…
Clauses: 4.1
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3319/3/20
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
A UK health professional complained about promotional material for Symbicort (budesonide/formoterol) created by AstraZeneca UK Ltd and hosted on the Guidelines in Practice website.The complaint foc…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3322/3/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
A UK health professional complained about two videos hosted on the ‘Guidelines in Practice’ website: ‘Secondary event prevention and risk stratification in patients with symptomatic periphera…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3317/3/20
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Boehringer Ingelheim breached Clause 4.3 after omitting generic names next to Spiolto/Spiriva brand
An anonymous complainant (a concerned UK health professional) raised concerns about a Guidelines in Practice webpage hosting a Boehringer Ingelheim promotional video: “Respimat Soft Mist reusable…
Clauses: 4.3
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3310/2/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Indivior
An anonymous, non-contactable ex-employee complained about an online article in Pharmaceutical Market Europe (PME)/PMLiVE (Dec 2019) titled “As the opioid crisis grabs the headlines, the search f…
Clauses: NONE
2020 🔒 Subscribe
← Prev 11 12 13 14 15 16 17 Next → Page 14 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews